Stand Up To CancerScience has published in the DIA Global Forum detailing the advances in cancer treatment during the 20th century and into the future globalforum.diaglobal.org/issue/april-20… Stand Up To Cancer #StandUpToCancer

@SU2CScience is ready for day 5 of #AACR24 . Stay tuned and come check in at Booth 3756! #AACR24

Stand Up To CancerScience is on-site for #AACR24 . Stay tuned for updates about the exciting science being presented by Stand Up To Cancer researchers and come swing by Booth 3756 in the Exhibit Hall! #AACR24

. Stand Up To Cancer Convergence® researcher Vinod BalachandranMD Memorial Sloan Kettering Cancer Center is presenting research on personalized vaccines and pancreatic cancer #StandUpToCancer #AACR24

At the opening plenary session with Stand Up To Cancer Scientific Summit AI panel members Christina Curtis and Aviv Regev discussed ways to inspire science, fuel progress and revolutionize care #StandUpToCancer #AACR24

Getting ready to start Day 3 of #AACR24 . Lots of great work being discussed to push the field of cancer research forward. Also, come say hi to us at Booth 3756! #AACR24

.Stand Up To Cancer Convergence® researcher Benjamin D. Greenbaum Memorial Sloan Kettering Cancer Center is talking about how to define the immune phenotype of genomic repeats in cancer #StandUpToCancer #AACR24

Christopher Abbosh of the Stand Up To Cancer-LUNGevity Foundation-American Lung Association Dream Team is presenting his work about using ctDNA as a high-risk biomarker in early cancer #StandUpToCancer #AACR24

Day 2 at #AACR24 . We will keep posting presentations by Stand Up To Cancer researchers and come visit us in the Exhibit Hall at Booth 3756! #StandUpToCancer #AACR24

Stand Up To CancerScience is on-site for #AACR24 . Stay tuned for updates about the exciting science being presented by Stand Up To Cancer researchers and come swing by our booth in the Exhibit Hall #StandUpToCancer

Peter Lee of the Stand Up To Cancer-The Breast Cancer Research Foundation Convergence™ Team published a paper in Cell Reports Medicine showing that tumor-associated macrophages expressing PD-L1 are associated with good clinical outcomes in breast cancer. cell.com/cell-reports-m…

The Stand Up To Cancer Catalyst®-Genentech Team led by Matthew Block and Tina J Hieken MD from Mayo Clinic Comprehensive Cancer Center published in Nature Communications that the NeoACTIVATE trial showed impressive response rates. nature.com/articles/s4146…

2017 Stand Up To Cancer IRG recipient Immunoengineering Lab at Vanderbilt BME has developed a #nanoparticle vaccine platform for codelivery of peptide neoantigens and synergistic adjuvants to enhance response to #cancer vaccines. pubs.acs.org/doi/full/10.10…

Congratulations to Stand Up To Cancer Catalyst®-Mirati Therapeutics Team Co-Leader Scott Kopetz for being awarded the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research to be presented at #AACR24

Congratulations to Stand Up To Cancer Multiple Myeloma Dream Team member Timothy Rebbeck for being awarded the AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention to be presented at #AACR24